User: Guest  Login
Less Searchfields
Simple search
Title:

A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): CheckMate 9UT.

Document type:
Meeting Abstract
Author(s):
Hahn, Noah M.; Chang, Sam; Meng, Maxwell; Shore, Neal D.; Konety, Badrinath R.; Steinberg, Gary D.; Gschwend, Juergen; Nishiyama, Hiroyuki; Palou, Joan; Taylor, John A.; Lambert, Alexandre; Zhu, Li; Maeda, Toshiki; Raybold, Bradley; Fischer, Bruce S.; Jeyamohan, Chandrika; Zardavas, Dimitrios; Witjes, Fred
Journal title abbreviation:
J Clin Oncol
Year:
2020
Journal volume:
38 Suppl S
Journal issue:
15
Print-ISSN:
0732-183X
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX